Oxurion NV
XBRU:OXUR

Watchlist Manager
Oxurion NV Logo
Oxurion NV
XBRU:OXUR
Watchlist
Price: 0.28 EUR Market Closed
Market Cap: 374.2k EUR
Have any thoughts about
Oxurion NV?
Write Note

Relative Value

The Relative Value of one OXUR stock under the Base Case scenario is 0.78 EUR. Compared to the current market price of 0.28 EUR, Oxurion NV is Undervalued by 64%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

OXUR Relative Value
Base Case
0.78 EUR
Undervaluation 64%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
77
vs Industry
65
Median 3Y
12.7
Median 5Y
148 755.2
Industry
7.7
vs History
vs Industry
Median 3Y
-0.1
Median 5Y
-13 532.5
Industry
22.7
vs History
vs Industry
Median 3Y
-0.3
Median 5Y
-14 626
Industry
21.6
vs History
vs Industry
Median 3Y
-1
Median 5Y
-23 701.3
Industry
25.2
vs History
vs Industry
Median 3Y
-0.3
Median 5Y
-0
Industry
2.5
vs History
77
vs Industry
66
Median 3Y
13.5
Median 5Y
148 756.6
Industry
7.7
vs History
vs Industry
49
Median 3Y
33.9
Median 5Y
292 249.9
Industry
9
vs History
vs Industry
30
Median 3Y
-0.2
Median 5Y
-6 490.7
Industry
4.2
vs History
vs Industry
28
Median 3Y
-0.2
Median 5Y
-14 417.5
Industry
4.1
vs History
vs Industry
30
Median 3Y
-0.3
Median 5Y
-14 625.9
Industry
5.7
vs History
vs Industry
27
Median 3Y
-0.3
Median 5Y
-14 608.6
Industry
3.6
vs History
vs Industry
69
Median 3Y
2.5
Median 5Y
96 975.7
Industry
4.6

Multiples Across Competitors

OXUR Competitors Multiples
Oxurion NV Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
BE
Oxurion NV
XBRU:OXUR
343.7k EUR 4.1 -0 -0 -0
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 797 580.3 -179 646.3 -218 147.8 -215 658.5
US
Abbvie Inc
NYSE:ABBV
320.1B USD 5.8 63 15.6 24.1
US
Amgen Inc
NASDAQ:AMGN
150.5B USD 4.6 35.6 16.8 31.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.4B USD 11.3 -250.9 25 26.3
US
Gilead Sciences Inc
NASDAQ:GILD
113.8B USD 4 903.4 10 10
US
Epizyme Inc
F:EPE
94.1B EUR 1 863.9 -475.6 -517.9 -504.1
AU
CSL Ltd
ASX:CSL
135.4B AUD 5.9 33.1 20.5 25.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.9B USD 6 17.8 16.3 18.1
US
Seagen Inc
F:SGT
39.3B EUR 18 -55.1 -59.2 -53.4
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.6 -130.7 -105.2 -76.6
P/E Multiple
Earnings Growth
BE
Oxurion NV
XBRU:OXUR
Average P/E: 210.6
Negative Multiple: -0
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -179 646.3 N/A
US
Abbvie Inc
NYSE:ABBV
63
412%
US
Amgen Inc
NASDAQ:AMGN
35.6
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -250.9
42%
US
Gilead Sciences Inc
NASDAQ:GILD
903.4
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -475.6 N/A
AU
CSL Ltd
ASX:CSL
33.1
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.1 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -130.7 N/A
EV/EBITDA Multiple
EBITDA Growth
BE
Oxurion NV
XBRU:OXUR
Average EV/EBITDA: 17.4
Negative Multiple: -0
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -218 147.8 N/A
US
Abbvie Inc
NYSE:ABBV
15.6
29%
US
Amgen Inc
NASDAQ:AMGN
16.8
62%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25
43%
US
Gilead Sciences Inc
NASDAQ:GILD
10
16%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -517.9 N/A
AU
CSL Ltd
ASX:CSL
20.5
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.3
35%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.2 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -105.2 N/A
EV/EBIT Multiple
EBIT Growth
BE
Oxurion NV
XBRU:OXUR
Average EV/EBIT: 22.6
Negative Multiple: -0
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -215 658.5 N/A
US
Abbvie Inc
NYSE:ABBV
24.1
88%
US
Amgen Inc
NASDAQ:AMGN
31.8
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.3
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -504.1 N/A
AU
CSL Ltd
ASX:CSL
25.5
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.1
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.4 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.6 N/A

See Also

Discover More
Back to Top